Literature DB >> 15191695

Smooth muscle function and dysfunction in gallbladder disease.

Piero Portincasa1, Agostino Di Ciaula, Gerard P vanBerge-Henegouwen.   

Abstract

The gallbladder epithelium and smooth muscle layer are exposed to concentrated biliary solutes, including cholesterol and potentially toxic hydrophobic bile salts, which are able to influence muscle contraction. Physiologically, gallbladder tone is regulated by spontaneous muscle activity, hormones, and neurotransmitters released into the muscle from intrinsic neurons and extrinsic sympathetic nerves. Methods to explore gallbladder smooth muscle function in vitro include cholecystokinin (CCK) receptor-binding studies and contractility studies. In human and animal models, studies have focused on cellular and molecular events in health and disease, and in vitro findings mirror in vivo events. The interplay between contraction and relaxation of the gallbladder muscularis leads in vivo to appropriate gallbladder emptying and refilling during fasting and postprandially. Defective smooth muscle contractility and/or relaxation are found in cholesterol stone-containing gallbladders, featuring a type of gallbladder leiomyopathy; defects of CCKA receptors and signal transduction may coexist with abnormal responses to oxidative stress and inflammatory mediators. Abnormal smooth musculature contractility, impaired gallbladder motility, and increased stasis are key factors in the pathogenesis of cholesterol gallstones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191695     DOI: 10.1007/s11894-004-0043-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  127 in total

1.  Myosin light chain phosphorylation correlates with contractile force in guinea pig gallbladder muscle.

Authors:  H P Parkman; R Garbarino; J P Ryan
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Cholesterol gallstone formation. 2. Pathobiology and pathomechanics.

Authors:  J T Lamont; M C Carey
Journal:  Prog Liver Dis       Date:  1992

3.  Mechanisms of gallbladder hypomotility in pregnant guinea pigs.

Authors:  Z L Xiao; Q Chen; P Biancani; J Behar
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

4.  Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients.

Authors:  M F Stolk; K J Van Erpecum; T L Peeters; M Samsom; A J Smout; L M Akkermans; G P Vanberge-Henegouwen
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

5.  Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin.

Authors:  Masahito Kano; Junichi Shoda; Susumu Satoh; Masakazu Kobayashi; Yasushi Matsuzaki; Masato Abei; Naomi Tanaka
Journal:  J Lab Clin Med       Date:  2002-05

6.  Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones.

Authors:  P Portincasa; A Di Ciaula; G Vendemiale; V Palmieri; A Moschetta; G P Vanberge-Henegouwen; G Palasciano
Journal:  Eur J Clin Invest       Date:  2000-04       Impact factor: 4.686

7.  Mechanisms of impaired gallbladder contractile response in chronic acalculous cholecystitis.

Authors:  Anders R Merg; Scott E Kalinowski; Marilyn M Hinkhouse; Frank A Mitros; Kimberly S Ephgrave; Joseph J Cullen
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

8.  Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity.

Authors:  Q Chen; J Amaral; P Biancani; J Behar
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

Review 9.  Role of CCK in gallbladder function.

Authors:  B T Schjoldager
Journal:  Ann N Y Acad Sci       Date:  1994-03-23       Impact factor: 5.691

10.  Effect of endothelin-1 on guinea pig gallbladder smooth muscle in vitro.

Authors:  C Moummi; G W Gullikson; T S Gaginella
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

View more
  17 in total

Review 1.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

Review 2.  Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Authors:  Emilio Molina-Molina; Raquel Lunardi Baccetto; David Q-H Wang; Ornella de Bari; Marcin Krawczyk; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2018-06-14       Impact factor: 4.686

3.  Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease.

Authors:  B Lavoie; B Nausch; E A Zane; M R Leonard; O B Balemba; A C Bartoo; R Wilcox; M T Nelson; M C Carey; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

4.  Effect of Fructus Psoraleae on motility of gallbladder isolated smooth muscle strips from guinea pigs.

Authors:  Shan Jin; Mei Li; Mei-Ling Lin; Yong-Hui Ding; Song-Yi Qu; Wei Li; Tian-Zhen Zheng
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

Review 5.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

6.  Metabolomic study of serum from rabbits with acute acalculous cholecystitis.

Authors:  Zhituo Li; Huaishu Shen; Yingmei Zhang; Ming Lu; Xin Qiao; Xianzhi Meng; Bei Sun; Dongbo Xue; Weihui Zhang
Journal:  Inflamm Res       Date:  2012-05-23       Impact factor: 4.575

7.  Embryonic cholecystitis and defective gallbladder contraction in the Sox17-haploinsufficient mouse model of biliary atresia.

Authors:  Hiroki Higashiyama; Aisa Ozawa; Hiroyuki Sumitomo; Mami Uemura; Ko Fujino; Hitomi Igarashi; Kenya Imaimatsu; Naoki Tsunekawa; Yoshikazu Hirate; Masamichi Kurohmaru; Yukio Saijoh; Masami Kanai-Azuma; Yoshiakira Kanai
Journal:  Development       Date:  2017-04-21       Impact factor: 6.868

8.  Vitamin D and gallstone disease-A population-based study.

Authors:  Daniel Mønsted Shabanzadeh; Torben Jørgensen; Allan Linneberg; Lars Tue Sørensen; Tea Skaaby
Journal:  Endocrine       Date:  2016-10-01       Impact factor: 3.633

Review 9.  Steatocholecystitis and fatty gallbladder disease.

Authors:  Chung-Jyi Tsai
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

10.  Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.

Authors:  Helen H Wang; Piero Portincasa; Nahum Mendez-Sanchez; Misael Uribe; David Q-H Wang
Journal:  Gastroenterology       Date:  2008-03-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.